These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24161074)

  • 21. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease.
    Gaspoz JM; Coxson PG; Goldman PA; Williams LW; Kuntz KM; Hunink MG; Goldman L
    N Engl J Med; 2002 Jun; 346(23):1800-6. PubMed ID: 12050341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis.
    Shah H; Gondek K
    Clin Ther; 2000 Mar; 22(3):362-70; discussion 360-1. PubMed ID: 10963290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of universal and platelet reactivity assay-driven antiplatelet therapy in acute coronary syndrome.
    Coleman CI; Limone BL
    Am J Cardiol; 2013 Aug; 112(3):355-62. PubMed ID: 23631863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.
    Dember LM; Kaufman JS; Beck GJ; Dixon BS; Gassman JJ; Greene T; Himmelfarb J; Hunsicker LG; Kusek JW; Lawson JH; Middleton JP; Radeva M; Schwab SJ; Whiting JF; Feldman HI;
    Clin Trials; 2005; 2(5):413-22. PubMed ID: 16317810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of immediate access arteriovenous grafts versus standard grafts for hemodialysis.
    Mohapatra A; Yuo TH; Lowenkamp MN; Wagner JK; Dillavou ED; Chaer RA; Avgerinos ED
    J Vasc Surg; 2021 Feb; 73(2):581-587. PubMed ID: 32473345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of antiplatelet medication after surgical thrombectomy jeopardized arteriovenous graft longevity.
    Yeh CH; Huang TS; Wang YC; Huang PF; Huang TY; Chen TP; Yin SY
    J Vasc Access; 2017 May; 18(3):207-213. PubMed ID: 28478620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H; Beeber LS; Schwartz TA; Lewis G
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.
    Sud S; Mittmann N; Cook DJ; Geerts W; Chan B; Dodek P; Gould MK; Guyatt G; Arabi Y; Fowler RA; ;
    Am J Respir Crit Care Med; 2011 Dec; 184(11):1289-98. PubMed ID: 21868500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
    Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
    J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of aspirin associates with longer primary patency of hemodialysis grafts.
    Dixon BS; Beck GJ; Dember LM; Vazquez MA; Greenberg A; Delmez JA; Allon M; Himmelfarb J; Hu B; Greene T; Radeva MK; Davidson IJ; Ikizler TA; Braden GL; Lawson JH; Cotton JR; Kusek JW; Feldman HI;
    J Am Soc Nephrol; 2011 Apr; 22(4):773-81. PubMed ID: 21415156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
    Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
    Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Denmark kidney transplantation is more cost-effective than dialysis.
    Jensen CE; Sørensen P; Petersen KD
    Dan Med J; 2014 Mar; 61(3):A4796. PubMed ID: 24814915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of intrathecal drug therapy in management of chronic nonmalignant pain.
    Kumar K; Rizvi S; Bishop S
    Clin J Pain; 2013 Feb; 29(2):138-45. PubMed ID: 22699140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
    McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R
    J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of antiplatelet therapy in the durability of hemodialysis access.
    Locham S; Beaulieu RJ; Dakour-Aridi H; Nejim B; Malas MB
    J Nephrol; 2018 Aug; 31(4):603-611. PubMed ID: 29730781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
    BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.